Management of Chronic Kidney Disease with Electrolyte Abnormalities

Assessment and Diagnosis

The European Society of Cardiology suggests that a patient with chronic kidney disease (CKD) stage 3, as evidenced by a GFR of 31 mL/min/1.73m², presents with elevated BUN and fluid overload, requiring careful monitoring of electrolytes and renal function 1, 2
A high BUN/creatinine ratio of 39.7, as seen in a patient with elevated BUN of 80 mg/dL and a creatinine of 2.02 mg/dL, suggests pre-renal azotemia or volume overload, according to the European Heart Journal 1, 3
Mild hyponatremia (sodium 134 mEq/L) and serum osmolality of 295 mOsm/kg in a patient with CKD suggest possible fluid overload, as indicated by the European Journal of Heart Failure 1

The European Journal of Heart Failure recommends administering intravenous loop diuretics (furosemide) to address volume overload and reduce BUN in patients with CKD, starting with a moderate dose (40-80 mg IV) 1
The European Heart Journal suggests that loop diuretics are preferred over thiazides in patients with creatinine clearance <30 mL/min, and that adequate hydration with isotonic saline is necessary before administering diuretics to prevent further renal deterioration 1
Monitoring urine output to evaluate diuretic response is crucial, as indicated by the European Heart Journal, and signs of electrolyte imbalances, such as hypokalemia, should be watched for, especially with brisk diuresis 4, 1

The European Heart Journal advises avoiding nephrotoxic medications, particularly NSAIDs, which can worsen renal function in patients with CKD, and considering temporary dose reduction of ACE inhibitors or ARBs if renal function deteriorates significantly during treatment 1, 3
Evaluating potential causes of pre-renal azotemia, including volume depletion, decreased cardiac output, or renal artery stenosis, is necessary for patients with CKD and a BUN/creatinine ratio >20, as suggested by the European Heart Journal 1, 3

The American Journal of Kidney Diseases recommends considering nephrology referral if renal function deteriorates despite appropriate management, or if serum creatinine level is >250 μmol/L (2.5 mg/dL), and specialist supervision is necessary 1, 5
The European Heart Journal suggests that after acute management, focus should be on cardiovascular risk reduction, as patients with CKD have increased cardiovascular morbidity and mortality, and regularly monitoring renal function, electrolytes, and adjusting medications accordingly is crucial 1, 3, 5